Intel Has Soared 225% in 2026. Here's Where the AI Stock Could Be By the End of 2028

Intel’s Q1 revenue rose 7% year over year to $13.6 billion, while non-GAAP EPS of $0.29 beat the $0.01 consensus by a wide margin. Management is benefiting from 22% growth in DCAI to $5.1 billion and 16% growth in foundry revenue to $5.4 billion, with 18A yields improving 7% to 8% per month and potential Apple manufacturing wins ahead. Despite these operating positives, the stock looks expensive at 904x trailing earnings and the median 12-month price target implies about 25% downside, making the article’s stance cautiously mixed.

Analysis

Intel’s rerating is now less about multiple expansion and more about whether the company can convert narrative into durable unit economics. The market is effectively pricing a clean execution path across two businesses that historically punished patience: a cyclical data-center franchise and a foundry model that only works if yields improve faster than customer skepticism. That creates a fragile setup where incremental good news can still push the stock higher, but any slip in throughput, pricing, or capex discipline could compress the multiple quickly because expectations are already stretched.

The second-order winner is the broader AI infrastructure supply chain, especially upstream equipment and advanced packaging ecosystems, because Intel’s success implies higher utilization across the semiconductor stack. A credible external-foundry win would also pressure customers like AAPL to diversify away from single-vendor dependence, which is strategically positive for buyers but margin- and mix-negative for incumbent manufacturers. TSM’s near-term risk is not share loss in absolute terms, but a more crowded capacity market that can slow its pricing power at the margin if Intel becomes a viable overflow node.

The key contrarian point is that the market may be underestimating how quickly earnings can inflect if yield improvement and backlog conversion line up over the next 2-3 quarters. At the same time, consensus may be overconfident in the durability of the move: this is a stock that can gap on beats, but it can also mean-revert violently if guidance merely meets, rather than exceeds, the new bar. In other words, the setup favors tactical participation, not blind long exposure.

For the next 1-2 quarters, the most important catalyst is proof that foundry wins translate into gross margin, not just revenue, while DCAI demand remains supply-constrained. If either of those legs disappoints, the stock’s valuation can re-rate down faster than fundamentals deteriorate because the current price already embeds several years of flawless execution.

Key Decisions for Investors

• Stay tactically long INTC only on post-earnings pullbacks or guide-up inflections; target a 6-12 week holding period and use a tight 10-12% stop because the stock is priced for perfection.
• Consider a pairs trade: long INTC / short TSM over the next 3-6 months if you believe foundry share gains are real but still underappreciated; the trade benefits from Intel-specific upside without taking full foundry beta.
• For event-driven upside, buy INTC call spreads 1-2 quarters out rather than outright stock; this captures continued beat-and-raise potential while limiting drawdown if the multiple compresses.
• Trim or hedge NVDA/AI-exposed semiconductor baskets on strength if Intel’s customer wins broaden, since incremental fab capacity and vendor diversification can modestly dilute scarcity premiums over 6-12 months.
• Use AAPL as a secondary beneficiary only if Intel manufacturing news is confirmed; otherwise treat it as optionality, not a core long, because the strategic benefit is longer-dated than the headline suggests.